Table 5.
Multivariable analysis of predictors for late mortality
| OR (95% CI) a | P‐value | |
|---|---|---|
| (a) Clinical characteristics | ||
| Clinical Frailty Scale | 1.99 (1.50–2.63) | <0.001 |
| Age >65 years | 0.79 (0.25–2.51) | 0.691 |
| Confusion | 0.54 (0.20–1.46) | 0.228 |
| Active cancer | 4.35 (1.57–12.04) | 0.005 |
| Ischaemic heart disease | 1.95 (0.86–4.43) | 0.112 |
| Dementia | 2.85 (1.01–8.04) | 0.048 |
| (b) Laboratory parameters | ||
| Clinical Frailty Scale | 1.93 (1.48–2.51) | <0.001 |
| Haemoglobin (g/L) | 0.981 (0.961–1.001) | 0.056 |
| Neutrophils (× 109/L) | 1.05 (0.94–1.18) | 0.383 |
| eGFR (mL/min/1.73 m2) | 0.997 (0.981–1.013) | 0.694 |
| ALP (IU/L) | 1.003 (0.998–1.009) | 0.203 |
| Albumin (g/L) | 0.97 (0.89–1.05) | 0.478 |
ALP, alkaline phosphatase; CI, confidence interval; eGFR, estimated glomerular filtration rate; OR, odds ratio. Values in bold denote statistically significant results.
a
Odds ratios are derived from multivariable logistic regression with late mortality as the dependent variable, and CFS as well as (a) all clinical features, or (b) all laboratory parameters associated at univariable analysis with late mortality, as independent variables.